Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2008 2
2009 1
2010 1
2011 1
2014 1
2015 1
2016 4
2017 4
2018 1
2020 1
2021 4
2023 1
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Results by year

Filters applied: . Clear all
Page 1
GDE2/GDPD5 in neuroblastoma.
Matas-Rico E, van Veen M, Moolenaar WH. Matas-Rico E, et al. Oncotarget. 2017 Jan 24;8(4):5672-5673. doi: 10.18632/oncotarget.14233. Oncotarget. 2017. PMID: 28030823 Free PMC article. No abstract available.
Neuronal differentiation through GPI-anchor cleavage.
Matas-Rico E, van Veen M, Moolenaar WH. Matas-Rico E, et al. Cell Cycle. 2017 Mar 4;16(5):388-389. doi: 10.1080/15384101.2016.1259894. Epub 2016 Nov 18. Cell Cycle. 2017. PMID: 27860541 Free PMC article. No abstract available.
Autotaxin impedes anti-tumor immunity by suppressing chemotaxis and tumor infiltration of CD8+ T cells.
Matas-Rico E, Frijlink E, van der Haar Àvila I, Menegakis A, van Zon M, Morris AJ, Koster J, Salgado-Polo F, de Kivit S, Lança T, Mazzocca A, Johnson Z, Haanen J, Schumacher TN, Perrakis A, Verbrugge I, van den Berg JH, Borst J, Moolenaar WH. Matas-Rico E, et al. Cell Rep. 2021 Nov 16;37(7):110013. doi: 10.1016/j.celrep.2021.110013. Cell Rep. 2021. PMID: 34788605 Free PMC article.
Glycerophosphodiesterase GDE2 Promotes Neuroblastoma Differentiation through Glypican Release and Is a Marker of Clinical Outcome.
Matas-Rico E, van Veen M, Leyton-Puig D, van den Berg J, Koster J, Kedziora KM, Molenaar B, Weerts MJ, de Rink I, Medema RH, Giepmans BN, Perrakis A, Jalink K, Versteeg R, Moolenaar WH. Matas-Rico E, et al. Cancer Cell. 2016 Oct 10;30(4):548-562. doi: 10.1016/j.ccell.2016.08.016. Epub 2016 Sep 29. Cancer Cell. 2016. PMID: 27693046 Free article.
20 results